Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment

Lu, I; Heming, M; Cheung, P; Thomas, C; Dag, M; Giglio, G; Schroeter, C; Nelke, C; Wirth, T; König, S; Siveke, J; Klotz, L; Leo, M; Wiendl, H; Hagenacker, T; Meyer zu Hörste, G (2024)
In: Nature Communications, 15
Type of Publication: Research article (journal)

Association of obesity with disease outcome in multiple sclerosis

Lutfullin I, Eveslage M, Bittner S, Antony G, Flaskamp M, Luessi F, Salmen A, Gisevius B, Klotz L, Korsukewitz C, Berthele A, Groppa S, Then Bergh F, Wildemann B, Bayas A, Tumani H, Meuth SG, Trebst C, Zettl UK, Paul F, Heesen C, Kuempfel T, Gold R, Hemmer B, Zipp F, Wiendl H, Lünemann JD, German Competence Network Multiple Sclerosis (KKNMS) (2023)
In: Journal of Neurology, Neurosurgery and Psychiatry, 94(1)
Type of Publication: Research article (journal)

Dose-dependent expression of GFI1 alters metabolism in the haematopoietic progenitors and MLL::AF9-induced leukaemic cells

Patnana P.K.; Liu L.; Frank D.; Nimmagadda S.; Behrens M.; Ahmed H.; Xie X.; Liebmann M.; Wei L.; Gerdemann A.; Thivakaran A.; Humpf H.U.; Klotz L.; Dugas M.; Varghese J.; Trajkovic-Arsic M.; Siveke J.T.; Hanenberg H.; Opalka B.; Dührsen U.; Reinhardt H.C.; Guenther U.; von Bubnoff N.; Khandanpour C. (2023)
In: British Journal of Haematology, 202(5)
Type of Publication: Research article (journal)

Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response.

Teschner VE; Fleck AK; Walter C; Schwarze AS; Eschborn M; Wirth T; Steinberg OV; Schulte-Mecklenbeck A; Lu IN; Herrera-Rivero M; Janoschka C; Lünemann JD; Schwab N; Meyer Zu Hörste G; Varghese J; Gross CC; Pul R; Kleinschnitz C; Mader S; Meinl E; Stoll M; Wiendl H; Klotz L (2023)
In: Therapeutic Advances in Neurological Disorders, 16
Type of Publication: Research article (journal)

Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses.

Pfeuffer S, Rolfes L, Wirth T, Steffen F, Pawlitzki M, Schulte-Mecklenbeck A, Gross CC, Brand M, Bittner S, Ruck T, Klotz L, Wiendl H, Meuth SG (2022)
In: Journal of Neuroinflammation, 19(1)
Type of Publication: Research article (journal)

Publications

Contact

Top-Links

Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment Lu, I; Heming, M; Cheung, P; Thomas, C; Dag, M; Giglio, G; Schroeter, C; Nelke, C; Wirth, T; König, S; Siveke, J; Klotz, L; Leo, M; Wiendl, H; Hagenacker, T; Meyer zu Hörste, G (2024) In: Nature Communications, 15 Type of Publication: Research article (journal)
Dietary habits in patients with relapsing-remitting multiple sclerosis and their correlation with clinical signatures of disease activity Passlick, Johanna; Fleck, Ann-Katrin; Lauks, Sarah; Eveslage, Maria; Bergh, Florian Then; Kuempfel, Tania; Bittner, Stefan; Zipp, Frauke; Wiendl, Heinz; Klotz, Luisa (2024) In: Multiple Sclerosis, 29 Type of Publication: Research article (journal)
Association of obesity with disease outcome in multiple sclerosis Lutfullin I, Eveslage M, Bittner S, Antony G, Flaskamp M, Luessi F, Salmen A, Gisevius B, Klotz L, Korsukewitz C, Berthele A, Groppa S, Then Bergh F, Wildemann B, Bayas A, Tumani H, Meuth SG, Trebst C, Zettl UK, Paul F, Heesen C, Kuempfel T, Gold R, Hemmer B, Zipp F, Wiendl H, Lünemann JD, German Competence Network Multiple Sclerosis (KKNMS) (2023) In: Journal of Neurology, Neurosurgery and Psychiatry, 94(1) Type of Publication: Research article (journal)
Attenuation of immune activation in patients with multiple sclerosis on a wheat-reduced diet: a pilot crossover trial Engel, S.; Klotz, L.; Wirth, T.; Fleck, A.K.; Pickert, G.; Eschborn, M.; Kreuzburg, S.; Curella, V.; Bittner, S.; Zipp, F.; Schuppan, D.; Luessi, F. (2023) In: Therapeutic Advances in Neurological Disorders, 16 Type of Publication: Research article (journal)
Dose-dependent expression of GFI1 alters metabolism in the haematopoietic progenitors and MLL::AF9-induced leukaemic cells Patnana P.K.; Liu L.; Frank D.; Nimmagadda S.; Behrens M.; Ahmed H.; Xie X.; Liebmann M.; Wei L.; Gerdemann A.; Thivakaran A.; Humpf H.U.; Klotz L.; Dugas M.; Varghese J.; Trajkovic-Arsic M.; Siveke J.T.; Hanenberg H.; Opalka B.; Dührsen U.; Reinhardt H.C.; Guenther U.; von Bubnoff N.; Khandanpour C. (2023) In: British Journal of Haematology, 202(5) Type of Publication: Research article (journal)
Glycolytic interference blocks influenza A virus propagation by impairing viral polymerase-driven synthesis of genomic vRNA. Kleinehr J; Schöfbänker M; Daniel K; Günl F; Mohamed FF; Janowski J; Brunotte L; Boergeling Y; Liebmann M; Behrens M; Gerdemann A; Klotz L; Esselen M; Humpf HU; Ludwig S; Hrincius ER (2023) In: PLoS Pathogens, 19(7) Type of Publication: Research article (journal)
Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response. Teschner VE; Fleck AK; Walter C; Schwarze AS; Eschborn M; Wirth T; Steinberg OV; Schulte-Mecklenbeck A; Lu IN; Herrera-Rivero M; Janoschka C; Lünemann JD; Schwab N; Meyer Zu Hörste G; Varghese J; Gross CC; Pul R; Kleinschnitz C; Mader S; Meinl E; Stoll M; Wiendl H; Klotz L (2023) In: Therapeutic Advances in Neurological Disorders, 16 Type of Publication: Research article (journal)
Effectiveness and safety of cladribine in MS: Real-world experience from two tertiary centres. Pfeuffer S, Rolfes L, Hackert J, Kleinschnitz K, Ruck T, Wiendl H, Klotz L, Kleinschnitz C, Meuth SG, Pul R (2022) In: Multiple Sclerosis, 28(2) Type of Publication: Research article (journal)
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses. Pfeuffer S, Rolfes L, Wirth T, Steffen F, Pawlitzki M, Schulte-Mecklenbeck A, Gross CC, Brand M, Bittner S, Ruck T, Klotz L, Wiendl H, Meuth SG (2022) In: Journal of Neuroinflammation, 19(1) Type of Publication: Research article (journal)
Impact of disease-modifying therapies on humoral and cellular immune-responses following SARS-CoV-2 vaccination in MS patients. Trümpelmann S, Schulte-Mecklenbeck A, Steinberg OV, Wirth T, Fobker M, Lohmann L, Lünemann JD, Wiendl H, Gross CC, Klotz L (2022) In: Clinical and Translational Science, 15(7) Type of Publication: Research article (journal)